US BANCORP \DE\ - ZEALAND PHARMA A S ownership

ZEALAND PHARMA A S's ticker is ZEAL and the CUSIP is 98920Y304. A total of 15 filers reported holding ZEALAND PHARMA A S in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
US BANCORP \DE\ ownership history of ZEALAND PHARMA A S
ValueSharesWeighting
Q2 2022$7,000
-12.5%
5090.0%0.00%
Q1 2022$8,000
-33.3%
509
-7.3%
0.00%
Q4 2021$12,000
-29.4%
549
-2.1%
0.00%
Q3 2021$17,0000.0%561
-1.8%
0.00%
Q2 2021$17,000
+142.9%
571
+158.4%
0.00%
Q1 2021$7,0000.0%221
+3.3%
0.00%
Q4 2020$7,000
-30.0%
214
-17.7%
0.00%
Q3 2020$10,000
+11.1%
2600.0%0.00%
Q2 2020$9,000
+12.5%
260
+9.7%
0.00%
Q1 2020$8,0002370.00%
Other shareholders
ZEALAND PHARMA A S shareholders Q3 2021
NameSharesValueWeighting ↓
AWM Investment Company, Inc. 48,957$631,0000.10%
GOLDMAN SACHS GROUP INC 500,916$6,517,0000.00%
BANK OF AMERICA CORP /DE/ 220,523$2,869,0000.00%
WELLS FARGO & COMPANY/MN 100$1,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
US BANCORP \DE\ 509$7,0000.00%
CREDIT SUISSE AG/ 285$4,0000.00%
MORGAN STANLEY 6,705$87,0000.00%
UBS Group AG 351$4,0000.00%
JANE STREET GROUP, LLC 23,976$312,0000.00%
View complete list of ZEALAND PHARMA A S shareholders